Oops! Your browser version is not supported by our website.
Please use these following browsers to view this page:
Hovione today announced the signing of a partnership agreement with Ligand to significantly ramp up the production output of Captisol®
Safety First, Quality Always: We are continuously improving the safety of our operations with the patient’s safety in mind.
Hovione commitment to setting SBTs in line with the Paris Agreement
Effective May 1st, 2020
Innovations in Pharmaceutical Technology, IPT Online, 27 October 2025
BCSD Portugal, 23 July 2021
The agreement furthers Hovione´s ability to bring the benefits of continuous tableting, including reduced time to market and increased supply chain flexibility, to pharmaceutical customers globally
Google Chrome
Safari
Firefox
Edge